The Infancy of an International Pediatric Pharmacy Network

Knoppert, David; Arenas-López, Sara; McArtney, Rowena

doi:10.2165/00148581-200810020-00001

Cited by 6 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[24][25][26] It also aligns well with Global Research in Paediatrics (GRIP), a program newly funded by the European Commission through the Seventh Research Framework Program. Such training could be offered locally, through provision of written materials or by e-learning.…”

Section: Discussionmentioning

confidence: 99%

Pediatric Clinical Trials in Latin America and Guyana

et al. 2011

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Pediatric Clinical Trials in Latin America and Guyana

et al. 2011

View full text Add to dashboard Cite

show abstract

“…16 Notable effort has been made to begin development of an effective international pediatric pharmacy network mobilizing qualified personnel from a wide cross-section of dedicated organizations in concert with the IABMC. 17 Importantly, the discipline of pediatric pharmacy has very recently been recognized by the Board of Pharmaceutical Specialties. Pediatric pharmacists will shortly be able to undergo examination to obtain this recognition of excellence in pediatric practice.…”

Section: Discussionmentioning

confidence: 99%

An International Asset Map of Clinicians, Educators, and Researchers Pursuing Better Medicine Use in Children: Initial Findings

MacLeod

Greff

Knoppert

et al. 2016

Clin Pharma and Therapeutics

View full text Add to dashboard Cite

The world's 1.89 billion children (age 0-14) too frequently receive treatments that have not been validated through clinical pharmacology research, especially in low- and middle-income countries. Initial findings from an international asset map of professionals and clinician scientists available to address the needs for education, research, and treatment support suggest a critical shortage of clinical pharmacologists, clinical pharmacists, and other professionals with advanced training in the evaluation of therapies for childhood conditions and illnesses. A total of 497 individuals responded to a survey conducted between May 2015 and February 2016. An alarming signal is apparent showing that, while the overall resource pool is unquestionably limited, 87% of relevant qualified personnel are located in high-income countries. The data suggest an urgent need for targeted training in pediatric clinical pharmacology, with particular focus on the needs in Africa, Latin America, and most of Asia.

show abstract

“…We are beginning to see real breakthroughs because of the formation of research networks in Europe and North America [2][3][4][5][6][7][8][9][10] and are now poised to extend the advantages of such networking into Africa and Asia.…”

mentioning

confidence: 99%